Tag: nasdaq:kalv

May 28, 2019

KalVista Pharmaceuticals Presents KVD900 Data

KalVista Pharmaceuticals ( NASDAQ:KALV) has announced it has presented data at he C1 Inhibitor Deficiency and Angioedema Workshop in Budapest,...
December 3, 2018

5 Top NASDAQ Pharma Stocks Year-to-Date

With Q4 and 2018 almost over, the Investing News Network is taking a look back at the five top NASDAQ...
December 2, 2018

5 Top Weekly NASDAQ Biotech Stocks: Arsanis Gains 271 Percent

Arsanis, Tyme Technologies, CohBar, Cocrystal Pharma and Contrafect were last week's top gainers.
October 21, 2018

5 Top Weekly NASDAQ Biotech Stocks: MannKind Leads the Pack

MannKind, Sierra Oncology, Eiger BioPharmaceuticals, Aevi Genomic Medicine and KalVista Pharmaceuticals were last week's top gainers on the NASDAQ Biotechnology...
October 9, 2018

5 Top NASDAQ Pharma Stocks Q3 2018

With Q3 over and Q4 officially in the works, the Investing News Network is taking a look back at the...
October 7, 2018

5 Top Weekly NASDAQ Biotech Stocks: vTv Leads with 374 Percent

vTv Therapeutics, Trevena, Cyclacel Pharmaceuticals, Paratek Pharmaceuticals and Avadel Pharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index.
September 14, 2018

KalVista Pharmaceuticals Reports Fiscal First Quarter Results

KalVista Pharmaceuticals (NASDAQ:KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors,...